Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Cover story: Artificial intelligence is revolutionizing ion channel drug discovery by tackling the inherent complexity and therapeutic significance of these intricate membrane proteins. Advanced algorithms are now unlocking the elusive GluN1/GluN3A receptor, enabling efficient exploration of expansive chemical spaces despite limited structural and ligand data—ultimately uncovering promising new modulators with high precision. Doi: 10.1038/s41401-025-01710-8.